Pages that link to "Q45185811"

The following pages link to IV immunoglobulins as add-on treatment to methylprednisolone for acute relapses in MS. (Q45185811):

Displaying 44 items.

• Multiple sclerosis (Q26995437) (← links)
• EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses (Q28284851) (← links)
• Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature (Q31039951) (← links)
• Optic neuritis and the neuro-ophthalmology of multiple sclerosis (Q33288634) (← links)
• Acute tumefactive demyelinating lesions in a pediatric patient with known diagnosis of multiple sclerosis: review of the literature and treatment proposal (Q33405166) (← links)
• Management of acute exacerbations in multiple sclerosis. (Q33670934) (← links)
• EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases (Q34597256) (← links)
• Immune mediated diseases and immune modulation in the neurocritical care unit (Q35729575) (← links)
• Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses (Q35811145) (← links)
• Safety and effectiveness assessment of intravenous immunoglobulin in the treatment of relapsing-remitting multiple sclerosis: A meta-analysis (Q36070739) (← links)
• Treatment of children and adolescents with multiple sclerosis (Q36153390) (← links)
• Intravenous immunoglobulin and multiple sclerosis (Q36359691) (← links)
• Efficacy of Intravenous Immunoglobulin in Neurological Diseases. (Q36484438) (← links)
• Treatment of acute relapses in multiple sclerosis (Q36568671) (← links)
• Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation. (Q36592223) (← links)
• Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis (Q36602782) (← links)
• Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis (Q37052797) (← links)
• Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations (Q37324279) (← links)
• Diagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies (Q37562166) (← links)
• Immunomodulatory therapies in neurologic critical care (Q37602031) (← links)
• Treatment of multiple sclerosis in children and adolescents (Q37693918) (← links)
• The steroid-sparing effect of intravenous immunoglobulin in patients with autoimmune diseases (Q37754661) (← links)
• Therapeutic approaches to multiple sclerosis: an update on failed, interrupted, or inconclusive trials of neuroprotective and alternative treatment strategies (Q37783283) (← links)
• Management of children with multiple sclerosis (Q38002113) (← links)
• The management of pediatric multiple sclerosis (Q38036853) (← links)
• Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies (Q38137114) (← links)
• Intravenous immunoglobulin in neurology--mode of action and clinical efficacy (Q38308436) (← links)
• Can new chemical therapies improve the management of multiple sclerosis in children? (Q39024427) (← links)
• Therapeutic management of severe relapses in multiple sclerosis (Q39026942) (← links)
• Review: New advances in the treatment of neurological diseases using high dose intravenous immunoglobulins (Q41173378) (← links)
• Reducing costs while enhancing quality of care in MS. (Q41966640) (← links)
• Treatment of corticosteroid refractory optic neuritis in multiple sclerosis patients with intravenous immunoglobulin (Q42595540) (← links)
• IVIG trials in MS. Is albumin a placebo? (Q51777739) (← links)
• [Escalating immunomodulatory therapy of multiple sclerosis. Update (September 2006)] (Q79394825) (← links)
• Neuromyelitis optica (Q80833376) (← links)
• [High-dose intravenous immunoglobulins in the treatment of multiple sclerosis. An update] (Q81760821) (← links)
• Pediatric multiple sclerosis (Q82915741) (← links)
• Intravenous Immunoglobulins Are a Therapeutic Option in the Treatment of Multiple Sclerosis Relapse (Q83387130) (← links)
• Treatment of Multiple Sclerosis Exacerbations (Q83719917) (← links)
• [Intravenous immunoglobulins in multiple sclerosis. An update] (Q84367880) (← links)
• [Administration of intravenous immunoglobulins in neurology. An evidence-based consensus: update 2010] (Q84475530) (← links)
• Multiple sclerosis (Q84512085) (← links)
• Efficacy, safety, and quality-of-life of treatments for acute relapses of multiple sclerosis: results from a literature review of randomized controlled trials (Q91906748) (← links)
• Comparing Plasma Exchange to Escalated Methyl Prednisolone in Refractory Multiple Sclerosis Relapses (Q92256622) (← links)